Literature DB >> 6580906

Role of the fast-exchanging calcium compartment in the early cardiotoxicity of anthracycline analogs.

E Monti, F Piccinini, L Favalli, F Villani.   

Abstract

Two new anthracycline analogs, 4'-epi-doxorubicin and 4'-deoxydoxorubicin, were tested for their cardiotoxicity and their activity on calcium turnover in guinea pig heart. The df/dt was used as an index of contractile force; calcium turnover was studied by means of a radioisotopic technique. 4'-Epi-doxorubicin was found less cardiotoxic than doxorubicin, whereas 4'-deoxydoxorubicin was found almost completely devoid of cardiotoxicity. The different cardiotoxic activity was found to be linearly correlated with the relative capacity to inhibit the fast-exchanging calcium compartment in cardiac muscle: doxorubicin greater than 4'-epi-doxorubicin greater than 4'-deoxydoxorubicin. This result supports that the inhibition of calcium exchange is involved in development of the early cardiotoxicity of anthracyclines.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6580906     DOI: 10.1016/0006-2952(83)90354-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

Review 1.  Anthracycline analogs: the past, present, and future.

Authors:  R B Weiss; G Sarosy; K Clagett-Carr; M Russo; B Leyland-Jones
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Fructose-1,6-diphosphate reduces acute ECG changes due to doxorubicin in isolated rat heart.

Authors:  N Bernardini; R Danesi; M C Bernardini; M Del Tacca
Journal:  Experientia       Date:  1988-12-01

3.  The clinical syndrome of 5-fluorouracil cardiotoxicity.

Authors:  J F Ensley; B Patel; R Kloner; J A Kish; J Wynne; M al-Sarraf
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

4.  Phase II study of deoxydoxorubicin in previously untreated metastatic breast cancer.

Authors:  S Martino; B A Samal; B Redman; L Flaherty; M Kraut; M Simon; M Valdivieso
Journal:  Breast Cancer Res Treat       Date:  1990-12       Impact factor: 4.872

Review 5.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

6.  Doxorubicin cardiotoxicity is associated with alterations of plasma levels of atrial natriuretic factor.

Authors:  N Bernardini; C Agen; S Favilla; R Danesi; M Del Tacca
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

7.  Myocardial contractility and heart pharmacokinetics of adriamycin following a single administration in rat.

Authors:  E Monti; F Piccinini; F Villani; L Favalli
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.